Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study ...
Treatment with Endeavor Biomedicines’ experimental oral therapy ENV-101 (taladegib) improved lung function in people with IPF ...
This Veterans Day, columnist Samuel Kirton writes about the PACT Act, which expanded coverage for veterans exposed to toxic substances.
Objectives: To construct a differential diagnostic model for Non-Tuberculous Mycobacterial Lung Disease (NTM-LD) and Pulmonary Tuberculosis Lung Disease (PTB-LD). Methods: Retrospective analysis of ...
Abstract: The development of scar tissue (fibrosis) in the lungs is a hallmark of pulmonary fibrosis, a progressive lung disease. impairing its ability to function properly. Progressive nature leading ...
Abstract: Lung sound classification is of utmost importance for the detection and diagnosis of respiratory illnesses at the very early stages. The non-stationary property and the overlapping ...
In idiopathic pulmonary fibrosis, the lung tissue thickens and stiffens through proliferation of fibroblasts and invasion by inflammatory cells. One of the drivers of these processes is the enzyme ...
For U.S. patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slows the decline in forced vital capacity (FVC), according to a study presented at CHEST 2025, the annual meeting of the ...
Approval is based on results from Phase III FIBRONEER™-IPF trial, which showed statistically significant improvements in the absolute change from baseline in Forced Vital Capacity at 52 weeks with ...
BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results